1-3 of 3
Adele Fielding, MB BS, PhD
Close
Sort by
Journal Articles

Delays in Start of Intensification Therapy Are Common for Adults with Acute Lymphoblastic Leukemia, and Are Associated with Decreased Survival in Patients Who Undergo Allogeneic Stem Cell Transplant (SCT)

Anita J. Kumar, MDMS, Phyllis A. Gimotty, PhD, Joel Gelfand, MDMS, Georgina Buck, Jacob M. Rowe, MD, Anthony H Goldstone, MD, Adele Fielding, MB BS, PhD, David I Marks, Mark Litzow, Elisabeth Paietta, PhD, Hillard M. Lazarus, Martin S. Tallman, MD, Selina M. Luger, MD, Alison W. Loren, MDMS
Journal: Blood
Blood (2014) 124 (21): 208.
https://doi.org/10.1182/blood.V124.21.208.208
Published: 2014
Journal Articles

Barriers To Clinical Trial Enrolment For Teenagers and Young Adults With Acute Lymphoblastic Leukaemia: The Impact of Age Eligibility Criteria

Lorna Anne Fern, BSc, MSc, PhD, Clare Rowntree, PhD, Rachael E Hough, MD, Ajay J Vora, Adele Fielding, MB BS, PhD, Chris Mitchell, Nicholas Goulden, Robert Alston, PhD, Jillian Birch, MD, O'hara Catherine, PhD, Jeremy Whelan, MD FRCP
Journal: Blood
Blood (2013) 122 (21): 1401.
https://doi.org/10.1182/blood.V122.21.1401.1401
Published: 2013
Journal Articles

Evaluation Of IKZF1 Δ4-7 Deletion As a Suitable Marker For Minimal Residual Disease Monitoring; A Study Of 161 Consecutive Acute Lymphoblastic Leukaemia (ALL) Patients On The On-Going UKALL14 Trial

Nahid Zareian, Bella Patel, MBBS, FRCPath, Lena Rai-Shetty, PhD, Clare Rowntree, PhD, Andrew McMillan, FRCP, FRCPath, PhD, David I Marks, Tobias Menne, Paul Smith, Simon Purnell, Lynda Micklewright, Anthony V. Moorman, Adele Fielding, MB BS, PhD
Journal: Blood
Blood (2013) 122 (21): 1335.
https://doi.org/10.1182/blood.V122.21.1335.1335
Published: 2013